Design, setting and patients: Retrospective analysis of clinical records of a consecutive series of ITP patients referred to a gastrointestinal surgeon in a tertiary referral hospital for laparoscopic splenectomy between August 2005 and November 2007.
Results: Of 16 patients, seven were H. pylori-negative and underwent laparoscopic splenectomy. Nine were H. pylori-positive and successfully underwent H. pylori eradication therapy; five of the nine had an initial platelet response. Four patients had platelet counts > 100 × 109/L (reference range, 140–450 × 109/L) and were off all immunosuppression at 9 months; three had a sustained response beyond 12 months. One patient had an initial response at 3 months (15 × 109/L to 208 × 109/L), but relapsed 4 months after H. pylori eradication and underwent splenectomy with platelet count recovery. The remaining four patients showed no platelet response and subsequently underwent splenectomy.
Conclusion: Larger prospective studies are needed to fully ascertain the role of H. pylori in Australian patients with ITP. However, H. pylori eradication is simple and safe. H. pylori screening and eradication should be considered before immunosuppression or splenectomy.
- 1. Chong BH, Ho S-J. Autoimmune thrombocytopenia: review. J Thromb Haemost 2005; 3: 1763-1772.
- 2. Gasbarrini A, Franceschi F. Does H. pylori infection play a role in idiopathic thrombocytopenic purpura and in other autoimmune diseases? Am J Gastroenterol 2005; 100: 1271-1273.
- 3. Suzuki T, Matsushima M, Masui A, et al. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura — a randomized controlled trial. Am J Gastroenterol 2005; 100: 1265-1270.
- 4. Suvajdzic N, Stankovic B, Artiko V, et al. Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura: prospective cohort study. Platelets 2006; 17: 227-230.
- 5. Jackson S, Beck P, Pineo G, Poon M. Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of literature. Am J Hematol 2005; 78: 142-150.
- 6. Franchini M, Veneri D. Helicobacter pylori-associated immune thrombocytopenia: review. Platelets 2006; 17: 71-77.
- 7. Fujimura K, Kuwana M, Kurata Y, et al. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol 2005; 81: 162-168.
- 8. Kuwana M, Ikeda Y. Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies. Int J Hematol 2006; 84: 309-315.
- 9. Inaba T, Mizuno M, Take S, et al. Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. Eur J Clin Invest 2005; 35: 214-217.
- 10. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120: 574-596.
- 11. Vaira D, Vakil N. Blood, urine, stool, breath, money, and Helicobacter pylori. Gut 2001; 48: 287-289.
- 12. Gasbarrini A, Franceschie F, Tartaglione R, et al. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998; 352: 878.
- 13. Franchini M, Veneri D. Helicobacter pylori infection and immune thrombocytopenic purpura — an update. Helicobacter 2004; 9: 342-344.
- 14. Ishiyama M, Teramura M, Iwabe K, et al. Clonally expanded T-cells in the peripheral blood of patients with idiopathic thrombocytopenic purpura and Helicobacter pylori infection. Int J Hematol 2006; 83: 147-151.
- 15. Veneri D, De Matteis G, Solero P, et al. Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment. Platelets 2005; 16: 307-311.
- 16. Kohda K, Kuga T, Kogawa K, et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol 2002; 118: 584-588.
- 17. Veneri D, Krampera M, Franchini M. High prevalence of sustained remission of idiopathic thrombocytopenic purpura after Helicobacter pylori eradication: a long-term follow-up study. Platelets 2005; 16: 117-119.
- 18. Ando K, Shiamoto T, Tauchi T, et al. Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in ITP? Our experience and literature review. Int J Hematol 2003; 77: 239-244.
- 19. Stasi R, Rossi Z, Stipa E, et al. Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 2005; 118: 414-419.
- 20. Sato R, Murakami K, Watanabe K, et al. Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med 2004; 164: 1904-1907.
- 21. Michel M, Cooper N, Jean C, et al. Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 2004; 103: 890-896.
- 22. Michel M, Khellaf M, Desforges, et al. Autoimmune thrombocytopenic purpura and Helicobacter infection. Arch Intern Med 2002; 162: 1033-1036.
- 23. Jarque I, Andreu R, Llopis J, et al. Absence of platelet response after eradication of Helicobacter pylori infection in patients with idiopathic thrombocytopenic purpura. Br J Haematol 2001; 115: 1002-1003.
- 24. Takahashi T, Yujiri T, Tanizawa Y. Helicobacter pylori and chronic ITP: the discrepancy in the clinical responses to eradication therapy might be due to differences in the bacterial strains. Blood 2004; 104: 594.
- 25. Kodama M, Kitadai Y, Ito M, et al. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura. Helicobacter 2007; 12: 36-42.
- 26. Lam VT, Trinh LK, Wilson R. Helicobacter infection and treatment outcome in an urban Australian population. ANZ J Surg 2006; 76: 710-714.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.